These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
912 related items for PubMed ID: 24830318
1. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Tuck CJ, Muir JG, Barrett JS, Gibson PR. Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):819-34. PubMed ID: 24830318 [Abstract] [Full Text] [Related]
3. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Vakil N. Nutr Clin Pract; 2018 Aug; 33(4):468-475. PubMed ID: 29870082 [Abstract] [Full Text] [Related]
4. History of the low FODMAP diet. Gibson PR. J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673 [Abstract] [Full Text] [Related]
5. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059 [Abstract] [Full Text] [Related]
6. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. Valeur J, Røseth AG, Knudsen T, Malmstrøm GH, Fiennes JT, Midtvedt T, Berstad A. Digestion; 2016 Jan; 94(1):50-6. PubMed ID: 27487397 [Abstract] [Full Text] [Related]
7. Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review. Fisher K, Hutcheon D, Ziegler J. Nutr Clin Pract; 2020 Apr; 35(2):231-245. PubMed ID: 30937981 [Abstract] [Full Text] [Related]
8. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. Staudacher HM, Whelan K, Irving PM, Lomer MC. J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553 [Abstract] [Full Text] [Related]
9. [Insufficient evidence of the effect of the low FODMAP diet on irritable bowel syndrome]. Krogsgaard LR, Lyngesen M, Bytzer P. Ugeskr Laeger; 2015 Apr 27; 177(18):1503-7. PubMed ID: 25922242 [Abstract] [Full Text] [Related]
10. Food regulations: low FODMAP labeling and communication goals. Méance S, Giordano J, Chuang E, Schneider H. J Gastroenterol Hepatol; 2017 Mar 27; 32 Suppl 1():62-63. PubMed ID: 28244659 [Abstract] [Full Text] [Related]
11. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Gastroenterology; 2015 Nov 27; 149(6):1399-1407.e2. PubMed ID: 26255043 [Abstract] [Full Text] [Related]
15. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Szűcs Á, Huszár O, Pécsi D, Czimmer J. PLoS One; 2017 Mar 27; 12(8):e0182942. PubMed ID: 28806407 [Abstract] [Full Text] [Related]
16. Re-challenging FODMAPs: the low FODMAP diet phase two. Tuck C, Barrett J. J Gastroenterol Hepatol; 2017 Mar 27; 32 Suppl 1():11-15. PubMed ID: 28244664 [Abstract] [Full Text] [Related]
18. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders. Chumpitazi BP. Curr Opin Gastroenterol; 2020 Mar 27; 36(2):147-154. PubMed ID: 31850930 [Abstract] [Full Text] [Related]
19. Effects of Low-FODMAPS Diet on Irritable Bowel Syndrome Symptoms and Gut Microbiome. Su H, Li YT, Heitkemper MM, Zia J. Gastroenterol Nurs; 2019 Mar 27; 42(2):150-158. PubMed ID: 30946302 [Abstract] [Full Text] [Related]
20. [Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia]. Yepes IJ, Múnera MN, Martelo C. Biomedica; 2018 May 01; 38(0):61-68. PubMed ID: 29809329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]